Table 3.

Adverse outcomes stratified by use of anti-tumor necrosis factor (anti-TNF) medication.

Anti-TNF UsersNonusers
• 4 Infections; 3 cellulitis and 1 deep joint infection• 3 Infections; all cellulitis
• 1 Pneumonia• 4 Pneumonias
• 2 Revisions• 2 Deep vein thromboses
• 1 Revision